ThermoDox heat-activated liposome regulatory update

The COMP issued a positive opinion to grant Orphan Drug designation for Celsion's ThermoDox to treat hepatocellular carcinoma (HCC). The heat-activated liposome encapsulating doxorubicin is in Phase I...